Prescription drug · NDA
Lupkynis (Voclosporin) NDC 75626-001
Voclosporin 7.9 mg/1 · Capsule · Oral · Aurinia Pharma U.S., Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 75626-001-02 | 75626000102 | 3 PACKET in 1 CARTON (75626-001-02) / 4 BLISTER PACK in 1 PACKET (75626-001-01) / 15 CAPSULE in 1 BLISTER PACKMarketed from Jan 22, 2021 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Lupkynis
- Generic name (nonproprietary)
- voclosporin
- Active ingredients
- Voclosporin — 7.9 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Aurinia Pharma U.S., Inc.NDC labeler code 75626
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 213716
- Marketing start
- Listing expires
- Other FDA classes
- Calcineurin Inhibitors (Mechanism)Organic Anion Transporting Polypeptide 1B1 Inhibitors (Mechanism)Organic Anion Transporting Polypeptide 1B3 Inhibitors (Mechanism)P-Glycoprotein Inhibitors (Mechanism)
- Identifiers
- Product ID 75626-001_59e563df-ed2e-4a55-e063-6294a90a0b51SPL ID 59e563df-ed2e-4a55-e063-6294a90a0b51SPL set ID 9f489295-1156-52c7-5fd0-5c4c52f9b813RxCUI 2475400, 2475406UNII 2PN063X6B1
- Pharmacologic class
- Calcineurin Inhibitor Immunosuppressant
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N475626000102followed by a unit qualifier and the quantityPackage 75626-0001-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
LUPKYNIS is indicated in combination with a background immunosuppressive therapy regimen [see Clinical Studies ( 14 )] for the treatment of adult patients with active lupus nephritis (LN). Limitations of Use: Safety and efficacy of LUPKYNIS have not been established in combination with cyclophosphamide. Use of LUPKYNIS is not recommended in this situation. LUPKYNIS is a calcineurin-inhibitor immunosuppressant indicated in combination with a background immunosuppressive therapy regimen for the treatment of adult patients with active lupus nephritis (LN). ( 1 , 14 ) Limitations of Use: Safety and efficacy of LUPKYNIS have not been established in combination with cyclophosphamide. Use of LUPKYN…
Excerpt only. Read the full label for complete information.
About NDC 75626-001
- What is NDC 75626-001?
- 75626-001 is the product NDC for Lupkynis (voclosporin), Voclosporin 7.9 mg/1 capsule, listed with the FDA by Aurinia Pharma U.S., Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Lupkynis (Voclosporin).
- What is the active ingredient?
- Voclosporin.
- Who is the labeler?
- Aurinia Pharma U.S., Inc., NDC labeler code 75626. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Lupkynis?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.